Efficacy and Safety of Tofacitinib in Patients With COVID-19 Pneumonia
Clinical trial NCT04750317 · COMPLETED
Trial details
- NCT number
- NCT04750317
- Sponsor
- I.M. Sechenov First Moscow State Medical University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-11
- Primary completion
- 2020-08-01
- Enrollment
- 414
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.